Form N-CSR - Certified Shareholder Report:
SEC Accession No. 0001104659-25-119341
Filing Date
2025-12-08
Accepted
2025-12-08 16:52:33
Documents
14
Period of Report
2025-09-30
Effectiveness Date
2025-12-08

Document Format Files

Seq Description Document Type Size
1 N-CSR tm2527059d12_ncsr.htm N-CSR 1340237
2 EXHIBIT 99.CODEETH tm2527059d12_ex99-codeeth.htm EX-99.CODEETH 86713
3 EXHIBIT 99.CERT tm2527059d12_ex99-cert.htm EX-99.CERT 20548
4 EXHIBIT 99.906CERT tm2527059d12_ex99-906cert.htm EX-99.906CERT 6919
5 EXHIBIT 99.(C)(1) tm2527059d12_ex99-xcx1.htm EX-99.(C)(1) 84775
6 EXHIBIT 99.(C)(2) tm2527059d12_ex99-xcx2.htm EX-99.(C)(2) 88269
7 EXHIBIT 99.(D) tm2527059d12_ex99-xd.htm EX-99.(D) 164486
8 EXHIBIT 99.(E) tm2527059d12_ex99-xe.htm EX-99.(E) 160895
9 GRAPHIC tm2527059d12hqlreporti001.gif GRAPHIC 307376
10 GRAPHIC tm2527059d12hqlreporti002.gif GRAPHIC 1018
11 GRAPHIC tm2527059d12hqlreporti003.jpg GRAPHIC 16434
12 GRAPHIC tm2527059d12hqlreporti004.jpg GRAPHIC 4662
13 GRAPHIC tm2527059d12hqlreporti005.jpg GRAPHIC 7726
14 GRAPHIC tm2527059d12_ex99-xcx1img01.jpg GRAPHIC 13009
  Complete submission text file 0001104659-25-119341.txt   2437034
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: N-CSR | Act: 40 | File No.: 811-06565 | Film No.: 251556735